Back to Journals » Patient Preference and Adherence » Volume 2

Review of the safety, efficacy and patient acceptability of the levonorgestrel-releasing intrauterine system

Authors Chandra Kailasam, David Cahill

Published 21 October 2008 Volume 2008:2 Pages 293—301

DOI https://doi.org/10.2147/PPA.S3464

Review by Single-blind

Peer reviewer comments 2

Chandra Kailasam1, David Cahill2

1Bristol Centre for Reproductive Medicine, Southmead Hospital, Bristol, UK; 2Dept of Obstetrics and Gynaecology, University of Bristol, St Michael’s Hospital, Bristol, UK

Abstract: The levonorgestrel-containing intrauterine system is an extremely effective, reversible and safe form of long-term yet reversible birth control. In view of its efficacy, it is a safer alternative to permanent contraceptive methods such as sterilization. It is especially useful in situations where use of estrogen-containing contraceptives is contraindicated. While menstrual disturbances are a common side effect, proper counseling improves compliance. In addition to its contraceptive effect, the levonorgestrel intrauterine system offers potential therapeutic benefits in other clinical contexts, including menorrhagia, symptomatic fibroids, endometriosis, and endometrial protection.

Keywords: intrauterine device, levonorgestrel intrauterine device, contraception

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 

 

Readers of this article also read:

Design and development of a decision aid to enhance shared decision making by patients with an asymptomatic abdominal aortic aneurysm

Dirk T Ubbink, Anouk M Knops, Sjaak Molenaar, Astrid Goossens

Patient Preference and Adherence 2008, 2:315-322

Published Date: 2 November 2008

Reasons for noncompliance with five-yearly screening flexible sigmoidoscopy

Charlie Henri Viiala, John Kevin Olynyk

Patient Preference and Adherence 2008, 2:27-33

Published Date: 30 October 2008

Impact of clinical pharmacy services on renal transplant recipients’ adherence and outcomes

Marie A Chisholm-Burns, Christina A Spivey, Charlene Garrett, Herbert McGinty, Laura L Mulloy

Patient Preference and Adherence 2008, 2:287-292

Published Date: 17 October 2008

Are symbols useful and culturally acceptable in health-state valuation studies? An exploratory study in a multi-ethnic Asian population

Hwee-Lin, Wee, Shu-Chuen Li, Xu-Hao Zhang, Feng Xie, David Feeny, et al

Patient Preference and Adherence 2008, 2:271-276

Published Date: 2 October 2008

Physician and patient management of type 2 diabetes and factors related to glycemic control in Spain

Nicole Rae Yurgin, Kristina Secnik Boye, Tatiana Dilla, Núria Lara Suriñach, Xavier Badia Llach

Patient Preference and Adherence 2008, 2:87-95

Published Date: 8 April 2008

Medication adherence among heart and/or lung transplant recipients: An exploratory study

Rebecca A O’Brien, Parisa Aslani, Maria A Ciccia, Jo-anne E Brien

Patient Preference and Adherence 2008, 2:115-120

Published Date: 20 March 2008

Adherence to glatiramer acetate treatment for multiple sclerosis: the Brazilian experience

Tatiana de Melo Gomes de Oliveira, Ana Patricia Peres Fiore, Yára Dadalti Fragoso

Patient Preference and Adherence 2008, 2:41-46

Published Date: 5 March 2008